Article info
Ovarian Cancer
Bevacizumab Shows Activity in Patients With Low-Grade Serous Ovarian and Primary Peritoneal Cancer
- Address correspondence and reprint requests to Rachel N. Grisham, MD, Memorial Sloan Kettering Cancer Center, 300 E 66th St, New York, NY, 10065. E-mail: gynbreast{at}mskcc.org.
Citation
Bevacizumab Shows Activity in Patients With Low-Grade Serous Ovarian and Primary Peritoneal Cancer
Publication history
- Received January 1, 2014
- Accepted May 2, 2014
- First published July 1, 2014.
Online issue publication
July 01, 2014
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2014 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.